Medopad, Perfect Ward and Inhealthcare have been named as this year’s winners of Pfizer’s Healthcare Hub: London challenge. More: Pfizer names winners of Healthcare Hub Challenge Source: News
read moreAbbVie and Calico have expanded their agreement to develop treatments for age-related diseases for a further three years. More: AbbVie, Calico extend age-related diseases collaboration Source: News
read moreAstraZeneca and MSD have unveiled trial results showing that Lynparza significantly extended the time patients with ovarian cancer lived without their disease worsening in the first-line maintenance setting, which could significantly expand the drug’s reach. More: AZ/MSD pursue wider indication
read more© 1994 - 2026 B.M. Pharmaceuticals